Debt to Equity Ratio Chart

View Debt to Equity Ratio for QCLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 0.0195
March 31, 2026 0.00
December 31, 2025 0.00
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 0.0002
December 31, 2024 0.0007
September 30, 2024 0.0011
June 30, 2024 0.0675
March 31, 2024 0.0035
December 31, 2023 0.0038
September 30, 2023 0.0058
June 30, 2023 0.0095
March 31, 2023 0.0793
December 31, 2022 0.0096
September 30, 2022 0.0086
June 30, 2022 0.0106
March 31, 2022 0.0068
December 31, 2021 0.0063
September 30, 2021 0.0025
June 30, 2021 0.0024
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 0.0019
June 30, 2020 0.0848
Date Value
March 31, 2020
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.022
Corcept Therapeutics, Inc. 0.0133
Veru, Inc. 0.0945
Johnson & Johnson 0.5771
Eli Lilly & Co. 1.621